These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 1235202)
1. [Use of miscleron in the treatment of primary glaucoma]. Kachevanskaia IV Vestn Oftalmol; 1975; (5):5-6. PubMed ID: 1235202 [No Abstract] [Full Text] [Related]
2. [Critical review of clinical experimentation with clofibrate in coronary disease]. Azzena D; Astengo F Minerva Cardioangiol; 1973; 21(7):497-502. PubMed ID: 4756344 [No Abstract] [Full Text] [Related]
3. Effect of clofibrate on water metabolism in hypothalamic and ADH-resistant diabetes insipidus. László FA; Czakó L Acta Med Acad Sci Hung; 1973; 30(1):139-48. PubMed ID: 4784147 [No Abstract] [Full Text] [Related]
4. Atromid and glaucoma. Gloster J Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):567-9. PubMed ID: 4534192 [No Abstract] [Full Text] [Related]
5. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics]. Parodi FA; Caputo G Clin Ter; 1976 Dec; 79(6):571-81. PubMed ID: 1009761 [No Abstract] [Full Text] [Related]
6. [Therapeutic use of miscleron in patients with diabetes mellitus and cardiovascular disorders]. Spesivtseva VG; Kakhnovskiĭ IM; Dorokhova AS; Al'bert LB Sov Med; 1973 Dec; 36(12):26-31. PubMed ID: 4779361 [No Abstract] [Full Text] [Related]
7. [Comparative evaluation of the hypolipidemic effect of cetamiphen, polysponin and miscleron in middle-aged and elderly patients with hypertension]. Chaialo PP; Tokar' AV; Rudaia ES Vrach Delo; 1980 Nov; (11):52-3. PubMed ID: 7467262 [No Abstract] [Full Text] [Related]
9. [Use of miscleron on diabetes mellitus patients with peripheral circulatory disorders]. Kakhnovskiĭ IM Paskalov ES; Grishina IM; Sokolov IIu Probl Endokrinol (Mosk); 1974; 20(3):16-20. PubMed ID: 4217894 [No Abstract] [Full Text] [Related]
10. [Treatment of chronic ischemic cardiopathy with a combination of pyridinolcarbamate and clofibrate]. Guerrera G; Melina D Clin Ter; 1980 Mar; 92(5):533-47. PubMed ID: 7449327 [No Abstract] [Full Text] [Related]
11. [Carbacholine in the treatment of primary glaucoma]. Dalkowska A; Bartkowska-Orlowska M; Gogolkiewicz J Klin Oczna; 1973 Feb; 43(2):155-8. PubMed ID: 4805034 [No Abstract] [Full Text] [Related]
13. [Miscleron in the treatment of patients with atherosclerosis of the coronary and cerebal vessels]. Sivkov II; Kukes VG; Kirichenko LL; Fedosova NS; Ishmaeva KA Sov Med; 1971 Sep; 34(9):54-7. PubMed ID: 5121295 [No Abstract] [Full Text] [Related]
14. [Effect of phenformin and miscleron on the blood somatomedin activity level in breast cancer]. Vasil'eva IA; Bershteĭn LM; Ostroumova MN; Dil'man VM Vopr Onkol; 1980; 26(9):34-6. PubMed ID: 7423902 [TBL] [Abstract][Full Text] [Related]
15. Data on the treatment of arteriosclerotic and diabetic retinopathy. Pék L; Szentirmay K Ther Hung; 1974; 22(1):40-3. PubMed ID: 4844932 [No Abstract] [Full Text] [Related]
16. [The effect of nitrates and miskleron on the prostacyclin-thromboxane ratio and on the functional activity of the thrombocytes in stenocardia patients]. Volkov VI; Ladnyĭ AI Vrach Delo; 1989 Nov; (11):60-2. PubMed ID: 2514486 [TBL] [Abstract][Full Text] [Related]
17. [Determination of chlorphenoxyisobutyrate in the blood of chronic ischemic heart disease patients under prolonged miscleron treatment]. Gneushev ET; Utlinskaia MG; Shitov NN; Senik EA Farmakol Toksikol; 1980; 43(3):335-7. PubMed ID: 7449973 [TBL] [Abstract][Full Text] [Related]
18. [Effect of fenformin and miscleron on the delayed hypersensitivity reaction in breast cancer patients]. Bershteĭn LM; Buslaeva VP; Kondrat'ev VB; Ostroumova MN; Semiglazov VF Vopr Onkol; 1980; 26(12):28-31. PubMed ID: 7467216 [TBL] [Abstract][Full Text] [Related]